Chief, Division of General Surgical Oncology Fox Chase Cancer Center
General Surgery
Dr. Elin R. Sigurdson, MD
|
|
Give Review
Dr. Elin R. Sigurdson works in the field of General Surgery. She received awards:"America's Top Doctors", "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors", "Super Doctor" and "Fellow (FACS)". Elin Sigurdson is a published doctor. She has 41 publications published. The most current publication "Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers." Elin Sigurdson accepts Medicare.
Publications
- Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers.
- Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type.
- Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status.
- Patterns of nodal staging during Breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?
- Modern Chemotherapy Mitigates Adverse Prognostic Effect of Regional Nodal Metastases in Stage IV Colorectal Cancer.
- Advanced imaging modalities in early stage breast Cancer: preoperative use in the United States Medicare population.
- Association of Race and Socioeconomic Status and Outcomes of Patients with Rectal Cancer.
- Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, ox...
- The Effect of Simultaneous Peripheral Excision in Breast Conservation upon Margin Status.
- Five-year Local Control in a Phase II Study of Hypofractionated Intensity Modulated Radiation Therapy With an Incorporated Boost for Early Stage Breast Cancer.
- Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast Cancer: the Fox Chase Cancer Center experience.
- Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation.
- Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma.
- Outcome and Natural History of Patients with Stage IV Colorectal Cancer Receiving Chemotherapy Without Primary Tumor Resection.
- Assessing Compliance with National Comprehensive Cancer Network Guidelines for Elderly Patients with Stage III Colon Cancer: The Fox Chase Cancer Center Partners' Init...
- Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation.
- Centralization of Cancer surgery: implications for patient access to optimal care.
- Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status.
- Young age is not associated with increased local recurrence for DCIS treated by Breast-conserving surgery and radiation.
- Use of molecular imaging to predict clinical outcome in patients with rectal Cancer after preoperative chemotherapy and radiation.
- NCCN clinical practice guidelines in oncology: hepatobiliary Cancers.
- Dermal lymphatic invasion and inflammatory breast Cancer are independent predictors of outcome after postmastectomy radiation.
- A prospective feasibility trial to determine the significance of the sentinel node gradient in breast Cancer: a predictor of nodal metastasis location.
- Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leu...
- Diagnosis and treatment of metastatic Disease to the liver.
- Impact of tumor location on nodal evaluation for colon Cancer.
- Four-week course of radiation for breast Cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
- Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal Cancer.
- Liver-directed therapies for patients with primary liver Cancer and hepatic metastases.
- Liver-directed therapies for hepatocellular Carcinoma.
- Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal Cancer: a randomized trial of efficacy, quality of life, and molecular markers...
- Colon Cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
- The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast Cancer.
- Locoregional strategies for coloRectal hepatic metastases.
- Accuracy of determining nodal negativity in colorectal Cancer on the basis of the number of nodes retrieved on resection.
- Lymph node dissection: is it diagnostic or therapeutic?
- Surgical treatment of Liver metastases.
- Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms.
- Combined-modality treatment for resectable metastatic coloRectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusi...
- Invasive mucinous carcinoma arising in ectopic axillary Breast tissue: a case report and literature review.
Schools
University Of Toronto Faculty Of Medicine
University Toronto
Meml Sloan Kettering Canc Center
Procedures Preformed
- Appendectomy, Open
- Biopsy of Breast
- Breast Reconstruction
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Super Doctor
- Fellow (FACS)
Education
-
University of Toronto Faculty of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1871515056 | |
| NPPES Provider LastName | SIGURDSON | |
| NPPES Provider FirstName | ELIN | |
| NPPES Provider ZIPCode | 191112434 | |
| NPPES Provider State | PA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 16.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871515056 |
| Last Name Of The Provider | SIGURDSON |
| First Name Of The Provider | ELIN |
| View All |
Similar Doctors
|
|
Dr. Aliza M. Olive, MD |
|
|
Dr. Julia H. Terhune, MD |
|
|
Dr. Anna M. Mazor, DO |
|
|
Dr. David S. Mills, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew P. Kochuba, MD |
|
|
Dr. Michael B. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Brown, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindsay E. Kuo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Basit K. Achakzai, MD |
|
|
Dr. Esther Tseng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jon S. Ivey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kathleen Reilly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abraham Shaked, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Andreas Karachristos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter L. Abt, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|